Keele Research Repository

Article

Sprigg, N, Flaherty, K, Appleton, JP, Salman, RA-S, Bereczki, D, Beridze, M, Ciccone, A, Collins, R, Dineen, RA, Duley, L, Egea-Guerrero, JJ, England, TJ, Karlinski, M, Krishnan, K, Laska, AC, Law, ZK, Ovesen, C, Ozturk, S, Pocock, SJ, Roberts, I, Robinson, TG, Roffe, C ORCID: https://orcid.org/0000-0002-5259-6649, Peters, N, Scutt, P, Thanabalan, J, Werring, D, Whynes, D, Woodhouse, L and Bath, PM (2019) Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT. Health Technology Assessment, 23 (35). 1 - 48.

Sprigg, N, Flaherty, K, Appleton, J, Salman, R, Bereczki, D, Beridze, M, Christensen, H, Ciccone, A, Collins, R, Czlonkowska, A, Dineen, R, Duley, L, Egea-Guerrero, J, England, T, Krishnan, K, Laska, AC, Law, ZK, Ozturk, S, Pocock, S, Roberts, I, Robinson, T, Roffe, C ORCID: https://orcid.org/0000-0002-5259-6649, Seiffge, D, Scutt, P, Thanabalan, J, Werring, D, Whynes, D and Bath, P (2018) Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial. The Lancet, 391 (10135). pp. 2107-2115.